A case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine: a case report

A case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine: a case report

Abstract Background More than 4 billion doses of the Coronavirus disease (COVID-19) vaccine have been administered worldwide but the relationship between the different vaccines and the development of renal disease is unknown. We present a case of tubulointerstitial nephritis following administration...

Full description

Bibliographic Details
Main Authors: Samuel B. M. Williams, Stephen D. J. Holwill, Rhian L. Clissold, Coralie Bingham
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Nephrology
Subjects:
Acute kidney injury
Tubulointerstitial nephritis
COVID-19
Vaccination
Case report
Online Access:https://doi.org/10.1186/s12882-023-03089-2

Internet

https://doi.org/10.1186/s12882-023-03089-2

Similar Items